Literature DB >> 1312594

Neurological complications of HIV-1-seropositive internal medicine inpatients in Kinshasa, Zaire.

J H Perriëns1, M Mussa, M K Luabeya, K Kayembe, B Kapita, C Brown, P Piot, R Janssen.   

Abstract

Because little was known about the prevalence of neurological complications of human immunodeficiency virus type 1 (HIV-1) infection in Africa, we conducted a cross-sectional study among consecutive admissions to the internal medicine wards of Mama Yemo Hospital in Kinshasa, Zaire. Of the 196 patients studied, 104 (53%) were HIV-1 seropositive, of whom 50 (48%) had stage 3 and 49 (47%) had stage 4 HIV-1 infection according to the provisional WHO staging criteria for HIV infection. Neuropsychiatric abnormalities were present in 43 (41%) of 104 HIV-1-seropositive patients. Of the HIV-1-seropositive patients, 9 (8.7%; 95% confidence interval, 4-16%) were diagnosed as having possible HIV-1-associated dementia complex, 1 (1%) as having possible HIV-1 myelopathy, and 3 (2.7%) as having possible HIV-1-associated minor cognitive/motor disorder. Definitive diagnoses could not be made because there were no facilities for neuroimaging and neuropathology. Meningitis caused by cryptococcus was diagnosed in six (5.6%) and by Mycobacterium avium in two (2%) of the HIV-1 seropositive patients. Acute onset hemiplegia, believed to be due to stroke, was present in four (4%) of the HIV-1-seropositive patients. The prevalence of other central nervous system opportunistic infections and mass lesions, especially toxoplasmic encephalitis, could not be assessed. In this population of Zairian inpatients, the prevalence of neurological complications of HIV-1 infection was similar to that observed in industrialized countries among patients with advanced HIV disease.

Entities:  

Mesh:

Year:  1992        PMID: 1312594

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  13 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

2.  Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations.

Authors:  J-C Mwanza; L K Nyamabo; T Tylleskär; G T Plant
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 3.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

4.  HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.

Authors:  Adelina Holguin; Mwanza Banda; Elizabeth J Willen; Costantine Malama; Kaseya O Chiyenu; Victor C Mudenda; Charles Wood
Journal:  AIDS Behav       Date:  2011-11

Review 5.  Neurology and the Global HIV Epidemic.

Authors:  Ana-Claire Meyer
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

6.  Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.

Authors:  Walter Royal; Mariana Cherner; Jean Carr; Abdulrazaq G Habib; Abimbola Akomolafe; Alashl'e Abimiku; Manhattan Charurat; John Farley; Akinwande Oluyemisi; Ibrahim Mamadu; Joyce Johnson; Ronald Ellis; J Allen McCutchan; J Allen McCutchen; Igor Grant; William A Blattner
Journal:  J Neurovirol       Date:  2012-04-18       Impact factor: 2.643

Review 7.  Trends and Clinical Characteristics of HIV and Cerebrovascular Disease in Low- and Middle-Income Countries (LMICs) Between 1990 and 2021.

Authors:  George Ransley; Stanley Zimba; Yohane Gadama; Deanna Saylor; Laura Benjamin
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-20       Impact factor: 5.495

8.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

9.  The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study.

Authors:  Tesfaye Berhe; Yilma Melkamu; Amanuel Amare
Journal:  AIDS Res Ther       Date:  2012-04-10       Impact factor: 2.250

10.  Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.

Authors:  Judith Kwasa; Deanna Cettomai; Edwin Lwanya; Dennis Osiemo; Patrick Oyaro; Gretchen L Birbeck; Richard W Price; Elizabeth A Bukusi; Craig R Cohen; Ana-Claire L Meyer
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.